Clinical Trials Insight: 700020012
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2008
At a glance
- Drugs Danoprevir (Primary)
- Indications Hepatitis C; Viral hepatitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors InterMune
- 24 Sep 2008 Results will be presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Oct. 31 to Nov. 4, in San Francisco, California.
- 01 Nov 2007 Tolerability results reported in an InterMune media release dated 1 Nov 2007.
- 27 Dec 2006 New trial record.